13 completed, 13 recruiting, 3 not yet recruiting, 3 terminated. 23 Not applicable, 4 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 23 | Completed 10, Recruiting 8, Not yet recruiting 2, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 4 | 4 | Recruiting 4 |
| Phase 3 | 1 | Recruiting 1 |
Follow Ulcer Foot: new trials by email Literature Review of Ulcer Foot trials Research Report on Ulcer Foot
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nutritional Status in Adults With Diabetic Foot Ulcers Protein supplementation and nutrition education - Diabetic Foot Ulcers (DFU), Nutrition Assessment | Not yet recruiting | Hvidovre University Hospital | 30 | 2026-09-21 | 2026-09-18 | |
| Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal DFUs Standard of Care (SOC), Corplex P, Theracor - Diabetic Foot Ulcer (DFU), Ulcer Foot | Not applicable | Not yet recruiting | StimLabs | 272 | 2026-07-01 | 2026-03-04 |
| Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers Tri-Membrane Wrap™ DFU, Membrane Wrap™ DFU, Membrane Wrap-Lite™ DFU - Diabetic Foot Ulcer, Foot Ulcer Chronic | Not applicable | Recruiting | BioLab Holdings | 50 | 2026-01-02 | 2026-10-01 |
| Efficacy of a New Composition (BU002) for Debridement of Chronic Cutaneous Ulcers BU002, Polyhexanide 0.1% and betaine 0.1% gel - Ulcer Venous, Ulcer Foot | Not applicable | Recruiting | Universidad del Desarrollo | 80 | 2025-10-01 | 2026-05-26 |
| A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers XWRAP - Diabetic Foot, Foot Ulcer | Phase 4 | Recruiting | Applied Biologics, LLC | 60 | 2025-08-26 | 2026-02-11 |
| Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers Standard of Care DFU, Tri-Membrane Wrap™ DFU, Membrane Wrap™ DFU - Diabetic Foot, DFU | Phase 4 | Recruiting | BioLab Holdings | 650 | 2025-07-15 | 2025-07-28 |
| Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy Activate™ Matrix, AmnioDefend™ FT Matrix, Palisade™ DM Matrix - Diabetic Foot Ulcer, DFU | Phase 4 | Recruiting | Sequence LifeScience, Inc. | 350 | 2025-07-11 | 2026-05-19 |
| The Prospective, Double-blind, Multicenter, Placebo-controlled, Randomized, Comparative Clinical Trial Neovasculgen®, Placebo - Ulcer Foot, Mellitus Diabetes | Phase 3 | Recruiting | JSC NextGen | 144 | 2025-02-11 | 2026-02-05 |
| Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People Standard of Care, DermGEN™ - Diabetes Mellitus, Ulcer Foot | Not applicable | Not yet recruiting | DeCell Technologies Inc. | 120 | 2024-12-30 | 2024-07-03 |
| Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers. ACApatch™, caregraFT™, Standard of Care - Venous Leg Ulcer, Venous Leg | Phase 4 | Recruiting | Tiger Biosciences, LLC. | 340 | 2024-12-06 | 2026-09-22 |
| Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers Standard of Care, Axolotl DualGraft + SOC - Diabetic Foot, Ulcer Foot | Not applicable | Recruiting | Axolotl Biologix | 100 | 2024-09-23 | 2025-01-30 |
| Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care SLAM + SOC, SOC - Diabetic Foot Ulcer, Diabetic Foot | Not applicable | Recruiting | Applied Biologics, LLC | 124 | 2024-09-20 | 2024-11-20 |
| Transcutaneous CO₂ Therapy in Recurrent Hard-to-Heal Diabetic Foot Ulcers transcutaneous application of gaseous CO2 on lower part of the body - Ulcer Foot | Not applicable | Completed | University Medical Centre Ljubljana | 30 | 2024-09-01 | 2026-02-24 |
| Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs Standard of Care-DFU, AmnioCore - DFU, Amnio Quad-Core - DFU - Diabetic Foot Ulcer, Venous Leg Ulcer | Not applicable | Recruiting | Stability Biologics | 324 | 2024-08-01 | 2025-01-20 |
| Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs Standard of Care, Revita, Relese - Diabetic Foot Ulcer (DFU), Ulcer Foot | Not applicable | Recruiting | StimLabs | 272 | 2024-07-16 | 2026-03-02 |
| Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS) Percutaneous transluminal angioplasty - Diabetic Foot, Diabetes Mellitus | Not applicable | Recruiting | Heinrich-Heine University, Duesseldorf | 200 | 2024-02-01 | 2026-02-04 |
| Diabetes Footcare Companion App for Patients and Carers Conversational Agent/Chatbot App - Diabetes Mellitus Foot Ulcer, Diabetes Mellitus, Type 2 | Completed | Nanyang Technological University | 40 | 2023-06-23 | 2024-01-19 | |
| LSCI and Thermography in Diabetic Foot Patients Affected by Ulcer(s): (MY-FOOT-B) Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 | Withdrawn | Mario Negri Institute for Pharmacological Research | 2023-04-13 | 2024-03-15 | ||
| Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers Mirragen Advanced Wound Matrix, Fibracol - Diabetic Foot Ulcer, Ulcer Foot | Not applicable | Completed | ETS Wound Care, LLC | 148 | 2022-09-13 | 2025-11-10 |
| SDRM® vs. Collagen for Diabetic Foot Ulcers Wound debridement, Wound closure matrix application - Diabetic Foot, Ulcer Foot | Not applicable | Completed | Polymedics Innovations Inc. | 30 | 2022-07-01 | 2023-08-28 |
Showing 20 of 37. Sign in to see all of them.
Foot Ulcer (37) · Diabetic Foot (28) · Ulcer (11) · Diabetes Mellitus (9) · Leg Ulcer (9) · Varicose Ulcer (6) · Diabetes Complications (2) · Diabetes Mellitus, Type 2 (2) · Diabetic Neuropathies (2) · Peripheral Arterial Disease (2) · Anemia (1) · Diabetes Mellitus, Type 1 (1) · Diabetic Retinopathy (1) · Foot Diseases (1) · Foot Injuries (1)
Skin Diseases (37) · Skin and Connective Tissue Diseases (37) · Foot Diseases (36) · Skin Ulcer (36) · Endocrine System Diseases (32) · Cardiovascular Diseases (30) · Vascular Diseases (29) · Diabetic Angiopathies (28) · Leg Ulcer (28) · Diabetes Complications (26) · Diabetic Neuropathies (26) · Diabetes Mellitus (23) · Nutritional and Metabolic Diseases (11) · Pathologic Processes (11) · Pathological Conditions, Signs and Symptoms (11)
Standard of Care (5) · Angioplasty (1) · Exercise Therapy (1) · Nutrition Assessment (1)
Applied Biologics, LLC (2) · BioLab Holdings (2) · ETS Wound Care, LLC (2) · StimLabs (2) · Axolotl Biologix (1) · Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète (1) · ConvaTec Inc. (1) · Cumbria Partnership NHS Foundation Trust (1) · DeCell Technologies Inc. (1) · Heinrich-Heine University, Duesseldorf (1) · Holbaek Sygehus (1) · Hvidovre University Hospital (1) · Indiana University (1) · JSC NextGen (1) · King Hamad University Hospital, Bahrain (1)
United States (19) · United Kingdom (3) · Denmark (2) · Germany (2) · Canada (1) · Chile (1) · Egypt (1) · France (1) · Russia (1) · Singapore (1) · Slovenia (1)
David Armstrong, DPM, MD, PhD (4) · Charles M Zelen, DPM (2) · Robert Galiano, MD (2) · Brock A Liden, DPM (1) · Cesare Miranda, MD (1) · Chandan K Sen, PhD (1) · Christina Mastandrea (1) · Dured Dardari, MD (1) · Hans Gottlieb, Chief consultant, MD PhD (1) · Hans Lucas Busch, MD (1) · Joseph Schuster, DPM (1) · Leon Jonker, PhD (1) · Liew Hui Ling, MBBS (1) · Malene RB Larsen, MD (1)